TCT-221 Treatment Recommendations Based on SYNTAX Score II and Observed 3-year Mortality in the EXCEL Trial

Patrick W. Serruys,Carlos Collet,Yoshinobu Onuma,Marie-Angèle Morel,Ovidiu Dressler,Yiran Zhang,Martin B. Leon,Marie-Claude Morice,Philippe Généreux,David E. Kandzari,A. Pieter Kappetein,Joseph F. Sabik,Gregg W. Stone

Journal of the American College of Cardiology（2017）

引用 1|浏览31

暂无评分

摘要

The SYNTAX Score II (SSII) risk score was developed from the SYNTAX trial to predict 4-year mortality after left main (LM) or multivessel disease revascularization. SSII combines anatomic lesion data and selected clinical characteristics (age, sex, COPD, peripheral artery disease, LVEF, creatinine

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要